Jannine Versi - 25 May 2023 Form 3 Insider Report for Adamis Pharmaceuticals Corp

Role
Director
Signature
/s/ David C. Benedicto, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
25 May 2023
Net transactions value
$0
Form type
3
Filing time
30 May 2023, 18:13:13 UTC
SEC
View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney